KALA BIO, Inc. ( KALA) - Stock Earnings
KALA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -8.9 million USD | — USD |
| 2025Q2 | -11.2 million USD | — USD |
| 2025Q3 | -7.6 million USD | — USD |
| 2026Q2 Est. | — | — |
KALA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -44.8 million USD | 3.9 million USD |
| 2023 | -42.2 million USD | — USD |
| 2024 | -38.5 million USD | — USD |
| 2026 Est. | — | — |
KALA
Price: $3.61
52 week price:
Earnings Per Share: -5.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 45.2 million